Cefazolin (CAS 25953-19-9)

Cefazolin, a first-generation cephalosporin antibiotic, is extensively utilized in microbiological research due to its potent bactericidal properties against a wide range of Gram-positive bacteria. Its action mechanism is primarily through the inhibition of bacterial cell wall synthesis, specifically targeting the penicillin-binding proteins (PBPs) that are crucial for the maintenance and construction of the cell wall. By binding to these PBPs, Cefazolin disrupts the final transpeptidation step of peptidoglycan synthesis, leading to weakening of the cell wall and ultimately causing cell lysis. This makes it an excellent model for studying bacterial cell wall biosynthesis and its regulation. In research, Cefazolin is also used to investigate the mechanisms underlying antibiotic resistance, particularly the role of beta-lactamases that some bacteria produce to inactivate drugs like Cefazolin. The chemical′s effectiveness against methicillin-sensitive Staphylococcus aureus (MSSA) makes it a valuable tool in comparative studies with newer antibiotics to understand evolving resistance patterns. Additionally, Cefazolin′s molecular structure and pharmacodynamics provide insights into the design of novel cephalosporins with improved efficacy and resistance profiles. Research utilizing Cefazolin contributes to broader scientific knowledge on antibiotic action, resistance mechanisms, and potential strategies for overcoming bacterial defenses, aiding in the advancement of microbial management techniques.